Appointment of John Dionne and Michelle Scrimgeour as Independent Non-Executive Directors

Bridgepoint is pleased to announce the appointment of John Dionne and Michelle Scrimgeour as independent non-executive directors with effect from 1 July 2025.

Until he retired as a Senior Managing Director of Blackstone, John served as Global Head of the Private Equity Business Development and Investor Relations groups. He first joined Blackstone as the Founder and Chief Investment Officer of the Blackstone Distressed Securities Fund. Earlier in his career, John was a Partner and Portfolio Manager for Bennett Restructuring Funds, a Partner at Saugatuck Capital and a Director of Corporate Development for a predecessor of Thermo Fisher Scientific. He began his career at Price Waterhouse as a public accountant.

He is a Senior Lecturer of Business Administration at the Harvard Business School.

Michelle served as Chief Executive Officer of Legal & General Investment Management from July 2019 to December 2024. Before joining Legal & General, Michelle was Chief Executive Officer, EMEA, at Columbia Threadneedle Investments and was a member of the Executive Leadership Team of Ameriprise Financial. Earlier in her career she was Chief Risk Officer at M&G Investments and a Director of M&G Group Limited, which she joined in 2012 after a successful career at BlackRock. Michelle has served as Deputy Chair of the Investment Association, Chair of the Technology Working Group of the UK Government’s Asset Management Taskforce and was a member of the FCA’s Practitioner Panel.

On appointment, Michelle will become the Chair of the Audit and Risk Committee, and John will become a member of the Audit and Risk Committee.

Commenting on the appointments, Tim Score, Chair, said:

“I am delighted to welcome John and Michelle to the Board. Following a thorough appointment process, we are excited to have found two great candidates with extensive experience in asset management. Their respective experiences will be invaluable to the Bridgepoint Group as it continues to implement the strategy outlined at the Capital Markets Day in October 2024.”

Source

Receive our alerts newsletter

Related Alerts

Grow your Institutional Business

Don’t hesitate to contact us if you have any questions.

Herengracht 162
1016 BP Amsterdam
The Netherlands

Email: info@exelerating.com
KvK: 65727746
Btw: NL856234011B01

Privacy Statement

Exelerating

Top